Difference between revisions of "Category:5 alpha-reductase inhibitors"
Jump to navigation
Jump to search
(Created page with "A class of medications that inhibit the enzyme 5α-reductase. This prevents the conversion of testosterone to DHT, and has potential efficacy as part of a treatment regimen fo...") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Endocrine therapy" to "Category:Endocrine therapeutic") |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
A class of medications that inhibit the enzyme 5α-reductase. This prevents the conversion of testosterone to DHT, and has potential efficacy as part of a treatment regimen for [[prostate cancer]]. | A class of medications that inhibit the enzyme 5α-reductase. This prevents the conversion of testosterone to DHT, and has potential efficacy as part of a treatment regimen for [[prostate cancer]]. | ||
| + | |||
| + | [[Category:Endocrine therapeutic]] | ||
Latest revision as of 17:36, 3 February 2019
A class of medications that inhibit the enzyme 5α-reductase. This prevents the conversion of testosterone to DHT, and has potential efficacy as part of a treatment regimen for prostate cancer.
Pages in category "5 alpha-reductase inhibitors"
The following 2 pages are in this category, out of 2 total.